Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinggan Yishen Qufeng Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine at the Shanghai University of TCM. It is specifically designed for the management of high-risk and very-high-risk hypertension. The formula is typically used as an adjunctive therapy alongside standard Western antihypertensive medications. Its name reflects its core TCM therapeutic principles: 'Qinggan' (clearing liver fire), 'Yishen' (tonifying the kidney), and 'Qufeng' (expelling wind), which are traditional strategies for addressing the underlying imbalances associated with elevated blood pressure and related symptoms like dizziness and headache.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qinggan yishen qufeng formula.